These innovative medications , Retatrutide, represent a groundbreaking advancement in treating metabolic dysfunction and potentially associated ailments . They are classified as GLP-1 pathway https://mariahzirr845271.rimmablog.com/40126959/semaglutide-a-comprehensive-dive-into-glp-1-agents